Veritone and ZeroEyes Partner to Accelerate Real-Time Threat Alerts and Post-Event Investigations
August 12, 2026
Technology
-
-
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
August 12, 2026
-
Rekor Expands Patented Verification Technology into Voice, Opening New Market for GoSecure(TM)
August 12, 2026
-
LivePerson Urges Stockholders to Vote “FOR” Acquisition by SoundHound AI Ahead of August 20 Special Meeting
August 11, 2026
-
CETIN Networks Selects RADCOM for AI-Driven Assurance Across Its Mobile Network in Slovakia
August 11, 2026
-
Tradr Expands Lineup with Leveraged Funds on Everspin, SiTime and UMC
August 11, 2026
-
Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa
August 10, 2026
-
Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx’s DNA Polymerase IIIC Inhibitor Antibiotics
August 10, 2026
-
SEALSQ’s SEALQuantum Sovereign Quantum Vertical Stack Interconnects Its Growing Ecosystem as $200 Million SEALQuantum.com Initiative Enters Second Phase of Deployment in September
August 7, 2026
-
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
August 7, 2026
-
HeartCore Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
August 7, 2026
-
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 7, 2026
-
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 7, 2026
-
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
August 7, 2026
-
Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
-
Kaltura Announces Financial Results for Second Quarter 2026
August 5, 2026